NCT05323929Recruiting
The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma
Source: ClinicalTrials.gov · Last updated 14 Apr 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a single-center, prospective, group-controlled clinical trial, aiming to clarify the relationship between the depth of dissection and scar formation in the treatment of early gastric cancer by ESD, and to provide high-quality evidence-based medicine for the treatment of early gastric cancer.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 5 Apr 2022
- Start date
- Jan 2022
- Primary completion date
- Dec 2026
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05323929
What you commit to
- Study type: Interventional
- Planned participants: 200
- From Jan 2022 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Advanced gastric cancer; or undifferentiated gastric cancer lesions \> 2 cm in diameter; or differentiated gastric cancer with ulcer lesions \> 3 cm in diameter.
- Coagulation disorders.
- Serious heart, liver, kidney and other diseases, can not tolerate ESD treatment.
- Patients with gastric cancer complications such as gastrointestinal bleeding and perforation that need emergency treatment.
- Patients with other tumors, patients with a history of malignant tumors (except early carcinoma in situ.
Other
- Those who did not comply with the test requirements, obviously violated this protocol, or switched to other protocols in the middle of treatment.
- Patients with distant metastasis.
- The patient himself requests to withdraw from the trial.
- The researcher believes that the patient is not suitable to participate in this study.
Who the study is looking for
- Patients older than 18 years old and younger than 75 years old.
- Early gastric cancer (T1a stage) diagnosed by gastroscopy or ultrasonography, differentiated and no ulcer; or early gastric cancer (T1a stage), differentiated with ulcer, lesion diameter \<3cm; or early gastric cancer (T1a stage), undifferentiated and No ulcer, lesion diameter \<2cm.
- Pathological diagnosis of gastric cancer.
- No further treatment is required.
- Patients diagnosed for the first time without other serious gastrointestinal diseases.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Second Affiliated Hospital, School of Medicine, Zhejiang University Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.